Prosecution Insights
Last updated: November 04, 2026

Kilgourmd Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Kilgourmd Inc. is managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being handled by a single distinct examiner, MILLER, MAKENNA RYLEIGH, who is the busiest examiner for the portfolio. The portfolio is currently limited to a single distinct art unit, indicating a concentrated technical focus for the pending patent application. This centralization simplifies the administrative burden of tracking the application's progress through the patent office.

The busiest examiner pending count of 1 confirms that MILLER, MAKENNA RYLEIGH is the sole examiner responsible for the current pending workload. This examiner's perspective on the biotechnology and pharmaceutical claims will be the deciding factor for the application's success. With only a single distinct examiner and art unit, the company can focus its legal strategy on the specific preferences and prior art interpretations of a single individual. This prosecution profile suggests a very targeted entry into the biotechnology patent landscape.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MILLER, MAKENNA RYLEIGH 1 100.0% +0.0%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18535563 METHOD TO PREVENT OXIDATIVE STRESS IN THE SKIN OF THE SCALP THROUGH THE COMBINATION OF L-ASCORBIC ACID WITH ANTI-FUNGAL AGENTS MILLER, MAKENNA RYLEIGH —

Top Art Units

Art UnitApps
1611 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18535563 METHOD TO PREVENT OXIDATIVE STRESS IN THE SKIN OF THE SCALP THROUGH THE COMBINATION OF L-ASCORBIC ACID WITH ANTI-FUNGAL AGENTS MILLER, MAKENNA RYLEIGH 1611 §103 Final Rejection — Pending Dec 11, 2023

Managing Kilgourmd Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Kilgourmd Inc. have?

Kilgourmd Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Kilgourmd Inc. applications?

Makenna Ryleigh Miller has the most, with 1 of Kilgourmd Inc.'s pending office actions.

What technology area are Kilgourmd Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month